Literature DB >> 21087090

Physiology and pathophysiology of the RANKL/RANK system.

Reiko Hanada1, Toshikatsu Hanada, Josef M Penninger.   

Abstract

The TNF family molecule RANKL and its receptor RANK are key regulators of bone remodeling, lymph node formation, and mammary gland development during pregnancy. RANKL and RANK are also expressed in the central nervous systems (CNS). However, the functional relevance of RANKL/RANK in the brain was entirely unknown. Recently, our group reported that the RANKL/RANK signaling pathway has an essential role in the central regulation of body temperature via the prostaglandin axis. This review discusses novel aspects of the RANKL/RANK system as key regulators of fever and female basal body temperature in the CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087090     DOI: 10.1515/BC.2010.149

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  18 in total

Review 1.  RANKL inhibition: a promising novel strategy for breast cancer treatment.

Authors:  Eva González-Suárez
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 2.  Bone development: overview of bone cells and signaling.

Authors:  Anna Teti
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

3.  Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function.

Authors:  Julia T Warren; Wei Zou; Corinne E Decker; Nidhi Rohatgi; Christopher A Nelson; Daved H Fremont; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2015-11       Impact factor: 4.429

4.  Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.

Authors:  Nagesha Guthalu Kondegowda; Rafael Fenutria; Ilana R Pollack; Michael Orthofer; Adolfo Garcia-Ocaña; Josef M Penninger; Rupangi C Vasavada
Journal:  Cell Metab       Date:  2015-06-18       Impact factor: 27.287

5.  Circulating Receptor Activator of Nuclear Factor-κB (RANK), RANK ligand (RANKL), and Mammographic Density in Premenopausal Women.

Authors:  Adetunji T Toriola; Catherine M Appleton; Xiaoyu Zong; Jingqin Luo; Katherine Weilbaecher; Rulla M Tamimi; Graham A Colditz
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-23

6.  Functional evolution of leptin of Ochotona curzoniae in adaptive thermogenesis driven by cold environmental stress.

Authors:  Jie Yang; Timothy G Bromage; Qian Zhao; Bao Hong Xu; Wei Li Gao; Hui Fang Tian; Hui Jun Tang; Dian Wu Liu; Xin Quan Zhao
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

7.  Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.

Authors:  Rachel Mintz; Mei Wang; Shuai Xu; Graham A Colditz; Chris Markovic; Adetunji T Toriola
Journal:  Breast Cancer Res       Date:  2022-04-14       Impact factor: 6.466

8.  The mammalian lectin galectin-8 induces RANKL expression, osteoclastogenesis, and bone mass reduction in mice.

Authors:  Yaron Vinik; Hadas Shatz-Azoulay; Alessia Vivanti; Navit Hever; Yifat Levy; Rotem Karmona; Vlad Brumfeld; Saja Baraghithy; Malka Attar-Lamdar; Sigalit Boura-Halfon; Itai Bab; Yehiel Zick
Journal:  Elife       Date:  2015-05-08       Impact factor: 8.140

9.  Regulation of neurite growth by tumour necrosis superfamily member RANKL.

Authors:  Humberto Gutierrez; Lilian Kisiswa; Gerard W O'Keeffe; Matthew J Smithen; Sean Wyatt; Alun M Davies
Journal:  Open Biol       Date:  2013-01-08       Impact factor: 6.411

10.  Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report.

Authors:  Javier A Neyra; Natalia A Rocha; Rhea Bhargava; Omkar U Vaidya; Allen R Hendricks; Aylin R Rodan
Journal:  BMC Nephrol       Date:  2015-07-30       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.